Top 4 wec3g.com competitors & alternatives
[WeC3G.com Learn about C3G & a community of people connecting to each other and to information, support, & resources focused on patients and caregivers living with & managing this rare, chronic disease affecting the kidneys. Register TODAY!]
wec3g.com competitors and alternatives
Top 4 wec3g.com competitors and alternatives are ranked by similar search terms, traffic and worth.
wec3g.com's top 5 competitors are: apellis.com with 200 daily traffic and 68,600 estimated worth, achillion.com with 12,000 daily traffic and 15,300 estimated worth, chemocentryx.com with 0 daily traffic and 14,900 estimated worth, atypicalhus.co.uk with 0 daily traffic and 0 estimated worth,
apellis.com
Official Home Page of the Apellis Pharmaceuticals Corporate Site | Apellis Pharmaceuticals
Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.
Daily Traffic: 200
Website Worth: $ 68,600
achillion.com
Alexion
Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.
Daily Traffic: 12,000
Website Worth: $ 15,300
chemocentryx.com
Amgen | A Worldwide Pioneer in Biotechnology
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Daily Traffic: 0
Website Worth: $ 14,900
atypicalhus.co.uk
Atypical Haemolytic Uraemic Syndrome (aHus) & Eculizumab
National Renal Complement Therapeutics Centre (NRCTC) Specialise In Atypical Haemolytic Uraemic Syndrome (aHUS), Eculizumab, C3 Glomerulopathy (C3G) & MPGN.
Daily Traffic: 0
Website Worth: $ 0
Share on Social Media
Similar sites like wec3g.com